U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06985238) titled 'Stratagen Quantitative Prostate MRI Platform Pilot Study' on April 22.
Brief Summary: The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions.
* What severe problems, if any, occur because of the use of the Stratagen Quantitative Prostate MRI Platform?
* Can the data collected be used to measure quantitative MRI parameters?
Participants will:
- Receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.
Study Start Date: June...